BofA cuts target for EssilorLuxottica stock to EUR 205.00
Published on 10/13/2026 at 09:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- BofA lowered its EssilorLuxottica price target from EUR 237.00 to EUR 205.00 while keeping a Buy rating.
- EssilorLuxottica reported EUR 7.692 billion in second-quarter 2026 revenue, up 7.20 percent year over year.
- The stock was EUR 147.63 at Lang & Schwarz on October 13, 2026, with a EUR 68.5 billion market capitalization.
- EssilorLuxottica is scheduled to publish its third-quarter 2026 revenue update on October 20, 2026.
EssilorLuxottica (ISIN FR0000121667) was trading at EUR 147.63 at Lang & Schwarz on October 13, 2026 at 9:32 a.m. CEST. As Investing.com reported on October 9, 2026, BofA Securities lowered its target from EUR 237.00 to EUR 205.00 while maintaining a Buy rating. The latest price sits EUR 8.37 above the 52-week low of EUR 138.30.
Target cut narrows valuation
The BofA reduction equals 13.50 percent from the former EUR 237.00 target. The new EUR 205.00 target lies 38.86 percent above the Lang & Schwarz price of EUR 147.63, using the same euro basis.
That contrast gives the analyst action two dimensions. BofA reduced its estimates but still described medium-term sales growth as mid- to high-single-digit and kept the Buy rating, while also pointing to a broadly flat margin excluding foreign-exchange effects.
Three dated company signals
On September 23, 2026, Finanztrends reported second-quarter 2026 revenue of EUR 7.692 billion, up 7.20 percent, and first-half adjusted operating profit growth of 15.00 percent at constant exchange rates. On September 29, 2026, Yahoo Finance carried the launch of Nuance Audio Plus, with a United States starting price of USD 829.00. On October 9, 2026, Investing.com reported the BofA target change to EUR 205.00.
What does the target cut mean?
The target revision shows that the analyst case still depends on execution rather than a simple recovery in the share price. EssilorLuxottica generated EUR 14.818 billion in second-quarter 2026 revenue and EUR 1.566 billion in net income, figures that frame the valuation debate with operating scale and earnings power.
Next revenue date is October 20
EssilorLuxottica's investor calendar lists October 20, 2026 for the third-quarter 2026 revenue release. The company had entered its quiet period on October 6, 2026, ahead of that publication, according to the EssilorLuxottica investor calendar.
Stock trades above Xetra close
At Lang & Schwarz, the stock was EUR 147.63 on October 13, 2026 at 9:32 a.m. CEST, plus EUR 0.88 or plus 0.60 percent versus the Xetra close of October 12, 2026 at EUR 146.75. The finance quote put market capitalization at EUR 68.5 billion and the 52-week range at EUR 138.30 to EUR 323.80 as of October 13, 2026. The further course of trading is shown by the continuously updated real-time quote of EssilorLuxottica stock.
EssilorLuxottica stock facts
- Company: EssilorLuxottica S.A.
- ISIN: FR0000121667
- Ticker: EL
- Primary exchange: Euronext Paris
- Price Lang & Schwarz as of October 13, 2026, 9:32 a.m. CEST: EUR 147.63
- Change versus Xetra close: plus 0.60 percent
- Xetra close October 12, 2026: EUR 146.75
- Market capitalization: EUR 68.5 billion as of October 13, 2026
- 52-week range: EUR 138.30-EUR 323.80 as of October 13, 2026
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Index membership: CAC 40 and Euro Stoxx 50
- Next earnings date: October 20, 2026
Market context: Market report CAC 40.
